Sunitinib 10-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Issue: May/Jun 2010 - Pain Management
View All Articles in Issue
Abstract: A formulation for preparing Sunitinib 10-mg/mL Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.
Related Keywords: Loyd V. Allen, Jr., PhD, RPh, formulation, sunitinib, cancer chemotherapy, antineoplastic agent, anticancer treatment, receptor tyrosine kinase inhibitor
Related Categories: CANCER AND AIDS, FORMULATIONS, GASTROENTEROLOGY, DOSAGE FORMS/DRUG CARRIERS
Download in electronic PDF format for $35